Skip to content

A study on improving muscle strength for people with psychiatric disorders using electrical stimulation with a belt-type electrode.

A Randomized Controlled Trial to Evaluate the Efficacy of Belt-Electrode Skeletal Muscle Electrical Stimulation for Improving Muscle Strength in Patients with Psychiatric Disorders. - The BESP Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058322
Enrollment
44
Registered
2025-06-30
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Various psychiatric disorders

Interventions

B-SES Intervention Arm. In addition to standard physical therapy, an intervention with Belt-electrode Skeletal muscle Electrical Stimulation (B-SES) will be conducted. Device is G-TES1100 (B-SES belt)
s choice) A. Strength training (body weight or machine, Borg 12-13) B. ADL movement training C. Balance training D. Ergometer: no load (pedaling only) or low load E. Psychiatric occupational ther

Sponsors

Nandan Senyo-kai Minamiawaji Hospital,
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients admitted to psychiatric care wards who give consent to participate in the study, can clearly express their wishes, and have a prescription for rehabilitation.

Exclusion criteria

Exclusion criteria: Individuals who meet any of the following criteria will be excluded from the study: Judged as unsuitable for participation by the attending physician. Inability to provide informed consent for the study. Severe hypertension (systolic blood pressure >= 200 mmHg or diastolic blood pressure >= 110 mmHg). Presence of an implanted pacemaker. History of epilepsy. Presence of sensory disorders or skin lesions at the stimulation site.

Design outcomes

Primary

MeasureTime frame
Knee extension strength at baseline (pre-intervention), 8 weeks, 12 weeks (end of intervention), and at 6-week follow-up.

Secondary

MeasureTime frame
The following outcomes assessed at baseline (pre-intervention), 12 weeks (end of intervention), and at 6-week follow-up: Quality of life assessed by the Sarcopenia Quality of Life (SarQoL) questionnaire Short Physical Performance Battery (SPPB) Neuropsychiatric Inventory-Questionnaire (NPI-Q) Medical Research Council (MRC) sum score

Countries

Japan

Contacts

Public ContactTomoki Kakehashi

Nandan Senyo-kai Minamiawaji Hospital Rehabilitation Department

kakehashi.tomoki@hmw.gr.jp0799531553

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026